(Q36760908)

English

Effects of ovarian surgery on the dopaminergic and opioidergic control of gonadotropin and prolactin secretion in women with polycystic ovarian disease

scientific article published on September 1993

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Effects of ovarian surgery on the dopaminergic and opioidergic control of gonadotropin and prolactin secretion in women with polycystic ovarian disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

author name string

Szilágyi A

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Hole R

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Keckstein J

3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Rossmanith WG

4

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

publication date

1 September 1993

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Gynecological Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

159-166

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

Inappropriate Secretion of Follicle-Stimulating Hormone and Luteinizing Hormone in Polycystic Ovarian Disease

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

The polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

Increased prolactin response to TRH in polycystic ovary syndrome with low basal prolactin values

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

The effect of laparoscopic treatment of polycystic ovarian disease by CO2-laser or Nd:YAG laser

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

The impact of ovarian laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

Endocrine dynamics during pulsatile GnRH administration in patients with hypothalamic amenorrhea and polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

The opioid control of LH and FSH release: effects of a met-enkephalin analogue and naloxone

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

The effects of prolonged opioidergic blockade on LH pulsatile secretion during the menstrual cycle

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

Evidence for altered catecholamine metabolism in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

Evidence for Increased Dopaminergic and Opioid Activity in Patients with Hypothalamic Hypogonadotropic Amenorrhea*

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

Hyperprolactinemia and sexual function in men.

1 reference

https://api.crossref.org/works/10.3109%2F09513599309152497

21 January 2018

Identifiers

10.3109/09513599309152497

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36760908&oldid=1655426732"